Low Serological Agreement of Hepatitis E in Immunocompromised Cancer Patients: A Comparative Study of Three Anti-HEV Assays
Significant variability among HEV serological assays highlights the challenges of reliable HEV diagnostics in immunosuppressed oncology patients. Assay selection and improved testing strategies are critical for this high-risk group.
Authors
- Mark Reinwald (ORCID: https://orcid.org/0000-0002-6506-2136)
- Isabel-Elena Haller (ORCID: https://orcid.org/0009-0009-0567-5158)
- Werner Dammermann (ORCID: https://orcid.org/0000-0001-6847-3769)
- Sandra Schwarzlose-Schwarck
- Franz A. M. Eggert (ORCID: https://orcid.org/0000-0003-0235-1720)
- Stefan Lüth (ORCID: https://orcid.org/0000-0001-9946-0960)
- Janine Kah
- Kristoph Jahnke
Institutions
- Universität Hamburg (DE)
- University of Potsdam (DE)
- Maastricht University (NL)
- University Medical Center Hamburg-Eppendorf (DE)
- Universitätsklinikum Brandenburg an der Havel (DE)
- Brandenburg University of Technology Cottbus-Senftenberg (DE)
Publication Details
- Journal
- Antibodies
- Published
- 2025-03-24
- DOI
- https://doi.org/10.3390/antib14020027
- Primary Topic
- Hepatitis Viruses Studies and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00